Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

HCFA Claim To Medicare Oversight Helped By Congressional Testimony, DoJ

Executive Summary

A proposed Medicare board "may not be the best choice of organizational structure" to oversee a new Medicare premium-support program, Medicare Payment Advisory Commission Chairman Gail Wilensky told a Senate Finance Committee hearing May 4.

You may also be interested in...



HHS Reorganization To Dismantle HCFA Recommended In Senate Testimony

The Health Care Financing Administration could be dismantled and its functions reassigned to new agencies without the need for legislative intervention, Patton Boggs Senior Health Policy Advisor Kathy Means said during a Senate Budget Committee hearing Feb. 15.

HHS Reorganization To Dismantle HCFA Recommended In Senate Testimony

The Health Care Financing Administration could be dismantled and its functions reassigned to new agencies without the need for legislative intervention, Patton Boggs Senior Health Policy Advisor Kathy Means said during a Senate Budget Committee hearing Feb. 15.

Medicare Rx Milestones: House Bill By Memorial Day, Enactment By July 4

Introduction of a drug benefit bill by Rep. Thomas (R-Calif.) before the Memorial Day recess is a near-term marker to predict the prospects for enactment of a Medicare prescription drug bill in 2000.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS035994

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel